CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-02 | Ho Tony W See Remarks | Shares withheld for taxes | −14,631 | $48.43 | $709K | 22,869 |
| 2018-08-01 | Ho Tony W See Remarks | Option exercise | +37,500 | 37,500 | ||
| 2018-08-01 | Ho Tony W See Remarks | Option exercise · Restricted Stock Units | −37,500 | 37,500 | ||
| 2018-07-05 | CAGNONI PABLO J Director | Option exercise | +1,684 | $5.59 | $9K | 1,684 |
| 2018-07-05 | CAGNONI PABLO J Director | Sale | −1,684 | $62.00 | $104K | 0 |
| 2018-07-05 | CAGNONI PABLO J Director | Option exercise · Stock Option (Right to Buy) | +1,684 | 86,333 | ||
| 2018-07-03 | CAGNONI PABLO J Director | Option exercise | +5,816 | $5.59 | $33K | 5,816 |
| 2018-07-03 | CAGNONI PABLO J Director | Sale | −5,816 | $62.00 | $361K | 0 |
| 2018-07-03 | CAGNONI PABLO J Director | Option exercise · Stock Option (Right to Buy) | +5,816 | 88,017 | ||
| 2018-06-15 | George Simeon Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-15 | EMSTER KURT VON Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-15 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-15 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2018-06-15 | Bolzon Bradley J PhD Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2018-06-15 | Woiwode Thomas Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2018-06-15 | Ho Tony W See Remarks | Grant or award · Stock Option (Right to Buy) | +43,000 | 43,000 | ||
| 2018-06-15 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +20,760 | 20,760 | ||
| 2018-06-15 | Kulkarni Samarth Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +109,000 | 109,000 | ||
| 2018-06-15 | CAGNONI PABLO J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-05 | EMSTER KURT VON Director | Option exercise | −2,000 | $5.75 | $12K | 19,236 |
Page 49 of 62 · 1,221 trades